Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07219030
PHASE1

A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

This study is to assess how oral emraclidine moves through the body of healthy elderly adult participants, and assess adverse events, and tolerability.

Official title: A Phase 1, Randomized, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Emraclidine Following Multiple Ascending Oral Doses in Healthy Elderly Subjects

Key Details

Gender

All

Age Range

65 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2025-10-08

Completion Date

2026-11

Last Updated

2025-11-10

Healthy Volunteers

Yes

Interventions

DRUG

Emraclidine

Oral tablets

DRUG

Placebo

Oral tablets

Locations (4)

Altasciences Clinical Los Angeles /ID# 276854

Cypress, California, United States

K2 Medical Research, LLC /ID# 276636

Maitland, Florida, United States

Clinical Pharmacology Of Miami /ID# 276856

Miami, Florida, United States

Acpru /Id# 276996

Grayslake, Illinois, United States